Filing Details
- Accession Number:
- 0001209191-14-011292
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-18 16:16:33
- Reporting Period:
- 2014-02-18
- Filing Date:
- 2014-02-18
- Accepted Time:
- 2014-02-18 16:16:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1211840 | Edward Hurwitz | C/O Macrogenics, Inc. 9640 Medical Center Drive Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2014-02-18 | 308,513 | $36.50 | 1,704,996 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
Footnotes
- These securities were sold as follows: 282,573 by Alta BioPharma Partners III, L.P. ("ABP III"), 18,977 by Alta BioPharma Partners III LP GmbH ("ABP III KG") and 6,963 by Alta Embarcadero BioPharma Partners III, LLC ("AEBP III"). Edward Hurwitz is a director of Alta BioPharma Management Partners III, LLC, which is the general partner of ABP III, the managing limited partner of ABP III KG and the manager of AEBP III.
- The shares are held as follows: 1,561,635 by ABPIII; 104,877 by ABPIII KG; and 38,484 by AEBP III. Edward Hurwitz disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.